MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis - PubMed (original) (raw)
MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis
Sachie Hiratsuka et al. Cancer Cell. 2002 Oct.
Free article
Abstract
The molecular mechanism of tissue-specific metastasis in tumors endogenously expressing members of the vascular endothelial growth factor (VEGF) family is not yet clear. Here we demonstrate that MMP9 is specifically induced in premetastatic lung endothelial cells and macrophages by distant primary tumors via VEGFR-1/Flt-1 tyrosine kinase (TK) and that it significantly promotes lung metastasis. In a genetic approach using mice, suppression of MMP9 induction by deletion of either VEGFR-1TK or MMP9 markedly reduced lung metastasis. Furthermore, the MMP9 levels in endothelial cells of normal lung lobes from patients carrying distant tumors were significantly elevated as compared with those from patients without tumors. Thus, a block of MMP9 induction via VEGFR-1 inhibition could be useful for the prevention of tumor metastasis in lung.
Similar articles
- Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S, Nakamura M, Ogawa F, Imai R, Murakami R, Kojima F, Majima M, Kitasato H. Maehana S, et al. Biomed Pharmacother. 2016 Dec;84:660-665. doi: 10.1016/j.biopha.2016.09.083. Epub 2016 Sep 30. Biomed Pharmacother. 2016. PMID: 27697638 - Social defeat stress promotes tumor growth and angiogenesis by upregulating vascular endothelial growth factor/extracellular signal-regulated kinase/matrix metalloproteinase signaling in a mouse model of lung carcinoma.
Wu X, Liu BJ, Ji S, Wu JF, Xu CQ, Du YJ, You XF, Li B, Le JJ, Xu HL, Duan XH, Dong JC. Wu X, et al. Mol Med Rep. 2015 Jul;12(1):1405-12. doi: 10.3892/mmr.2015.3559. Epub 2015 Mar 27. Mol Med Rep. 2015. PMID: 25824133 - Opposite angiogenic outcome of curcumin against ischemia and Lewis lung cancer models: in silico, in vitro and in vivo studies.
Fan S, Xu Y, Li X, Tie L, Pan Y, Li X. Fan S, et al. Biochim Biophys Acta. 2014 Sep;1842(9):1742-54. doi: 10.1016/j.bbadis.2014.06.019. Epub 2014 Jun 23. Biochim Biophys Acta. 2014. PMID: 24970744 - MMP9 potentiates pulmonary metastasis formation.
van Kempen LC, Coussens LM. van Kempen LC, et al. Cancer Cell. 2002 Oct;2(4):251-2. doi: 10.1016/s1535-6108(02)00157-5. Cancer Cell. 2002. PMID: 12398887 Review. - Premetastatic lung "niche": is vascular endothelial growth factor receptor 1 activation required?
Duda DG, Jain RK. Duda DG, et al. Cancer Res. 2010 Jul 15;70(14):5670-3. doi: 10.1158/0008-5472.CAN-10-0119. Epub 2010 Jun 29. Cancer Res. 2010. PMID: 20587530 Free PMC article. Review.
Cited by
- Malignancy through cooperation: an evolutionary game theory approach.
Liu Q, Liu Z. Liu Q, et al. Cell Prolif. 2012 Aug;45(4):365-77. doi: 10.1111/j.1365-2184.2012.00824.x. Epub 2012 May 18. Cell Prolif. 2012. PMID: 22607159 Free PMC article. - Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
Ghallab NA, Shaker OG. Ghallab NA, et al. Clin Oral Investig. 2017 Apr;21(3):937-947. doi: 10.1007/s00784-016-1846-8. Epub 2016 May 10. Clin Oral Investig. 2017. PMID: 27161218 - Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9.
Qian Z, Zhao X, Jiang M, Jia W, Zhang C, Wang Y, Li B, Yue W. Qian Z, et al. BMC Cancer. 2012 Oct 2;12:442. doi: 10.1186/1471-2407-12-442. BMC Cancer. 2012. PMID: 23031673 Free PMC article. - FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis.
Qian BZ, Zhang H, Li J, He T, Yeo EJ, Soong DY, Carragher NO, Munro A, Chang A, Bresnick AR, Lang RA, Pollard JW. Qian BZ, et al. J Exp Med. 2015 Aug 24;212(9):1433-48. doi: 10.1084/jem.20141555. Epub 2015 Aug 10. J Exp Med. 2015. PMID: 26261265 Free PMC article. - A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours.
Lassen U, Nielsen DL, Sørensen M, Winstedt L, Niskanen T, Stenberg Y, Pakola S, Stassen JM, Glazer S. Lassen U, et al. Br J Cancer. 2012 Feb 14;106(4):678-84. doi: 10.1038/bjc.2011.609. Epub 2012 Jan 24. Br J Cancer. 2012. PMID: 22333707 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous